No connection

Search Results

CYH vs IRD

CYH
Community Health Systems, Inc.
BEARISH
Price
$2.72
Market Cap
$383.3M
Sector
Healthcare
AI Confidence
85%
IRD
Opus Genetics, Inc.
BEARISH
Price
$5.36
Market Cap
$381.4M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
CYH
0.79
IRD
--
Forward P/E
CYH
20.81
IRD
-9.43
P/B Ratio
CYH
-0.25
IRD
24.36
P/S Ratio
CYH
0.03
IRD
26.86
EV/EBITDA
CYH
7.87
IRD
-8.75

Profitability

Gross Margin
CYH
41.6%
IRD
-117.05%
Operating Margin
CYH
6.44%
IRD
-296.33%
Profit Margin
CYH
3.77%
IRD
0.0%
ROE
CYH
--
IRD
-242.41%
ROA
CYH
4.68%
IRD
-55.39%

Growth

Revenue Growth
CYH
-6.1%
IRD
-10.2%
Earnings Growth
CYH
--
IRD
--

Financial Health

Debt/Equity
CYH
--
IRD
0.07
Current Ratio
CYH
1.47
IRD
6.43
Quick Ratio
CYH
1.19
IRD
6.2

Dividends

Dividend Yield
CYH
--
IRD
--
Payout Ratio
CYH
0.0%
IRD
0.0%

AI Verdict

CYH BEARISH

CYH exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 3/9 and a negative Price-to-Book ratio (-0.25), which indicates negative shareholders' equity. While the current P/E ratio appears deceptively low, the surge to a Forward P/E of 20.81 suggests a significant expected collapse in earnings. Revenue is contracting (-6.10% YoY) and the stock is in a persistent technical downtrend, losing 74% of its value over five years. The provided growth-based intrinsic value of $24.08 is fundamentally disconnected from the company's current balance sheet insolvency and should be disregarded.

Strengths
Very low Price-to-Sales ratio (0.03)
Current ratio of 1.47 indicates short-term liquidity
Positive operating and profit margins
Risks
Negative shareholders' equity (Price/Book: -0.25)
Weak Piotroski F-Score (3/9) indicating deteriorating fundamentals
Negative revenue growth (-6.10% YoY)
IRD BEARISH

The company exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. Most alarming is the negative gross margin of -117.05%, meaning the company loses money on every unit of revenue generated before operating expenses. Despite a speculative 654.9% price surge over the last year and a 'strong_buy' analyst consensus, the underlying data shows declining revenue (-10.20%) and extreme valuation multiples (P/B of 24.36). The stock appears to be trading on momentum or speculative expectations rather than any tangible financial health.

Strengths
Very low Debt/Equity ratio (0.07)
Strong short-term liquidity (Current Ratio 6.43)
Significant 1-year price momentum (+654.9%)
Risks
Negative gross margins (-117.05%) indicate a non-viable cost structure
Severe operational losses (Operating Margin -296.33%)
Declining revenue growth (-10.20% YoY)

Compare Another Pair

CYH vs IRD: Head-to-Head Comparison

This page compares Community Health Systems, Inc. (CYH) and Opus Genetics, Inc. (IRD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile